{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:46:28Z","timestamp":1792525588830,"version":"4.5.0"},"reference-count":155,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.resinv.2025.04.018","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:06:08Z","timestamp":1747487168000},"page":"639-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Eosinophilic granulomatosis with polyangiitis: current status and future perspectives"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7185-2273","authenticated-orcid":false,"given":"Yosuke","family":"Kamide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2025.04.018_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2025.04.018_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MD.0b013e318205a4c6","article-title":"The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort","volume":"90","author":"Guillevin","year":"2011","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2025.04.018_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10157-012-0767-3","article-title":"Clinicopathological features of neuropathy in anti-neutrophil cytoplasmic antibody-associated vasculitis","volume":"17","author":"Koike","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.resinv.2025.04.018_bib4","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib5","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-019-12515-9","article-title":"Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status","volume":"10","author":"Lyons","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.resinv.2025.04.018_bib6","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/art.41722","article-title":"Occupational exposures and smoking in eosinophilic granulomatosis with polyangiitis: a case-control study","volume":"73","author":"Maritati","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.alit.2019.06.004","article-title":"Update on eosinophilic granulomatosis with polyangiitis","volume":"68","author":"Furuta","year":"2019","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib8","first-page":"277","article-title":"Allergic granulomatosis, allergic angiitis, and periarteritis nodosa","volume":"27","author":"Churg","year":"1951","journal-title":"Am J Pathol"},{"key":"10.1016\/j.resinv.2025.04.018_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham","year":"1984","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2025.04.018_bib10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised international Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/RHU.0000000000001198","article-title":"Prevalence of eosinophilic granulomatosis with polyangiitis and associated health care utilization among patients with concomitant asthma in US commercial claims database","volume":"27","author":"Gokhale","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib13","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/rheumatology\/kez597","article-title":"Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway","volume":"59","author":"Nilsen","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1183\/23120541.00430-2023","article-title":"Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK","volume":"10","author":"Hwee","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2025.04.018_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/pds.1353","article-title":"Asthma drug use and the development of Churg-Strauss syndrome (CSS)","volume":"16","author":"Harrold","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.resinv.2025.04.018_bib16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0038-1669454","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"39","author":"Nguyen","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2019.108325","article-title":"Childhood GPA, EGPA, and MPA","volume":"211","author":"Jariwala","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.semarthrit.2008.05.004","article-title":"Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients","volume":"39","author":"Zwerina","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1145257","article-title":"Eosinophilic granulomatosis with polyangiitis - advances in pathogenesis, diagnosis, and treatment","volume":"10","author":"Fijolek","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib20","article-title":"Ten clinical conundrums in the management of eosinophilic granulomatosis with polyangiitis","volume":"5","author":"Rua-Figueroa","year":"2024","journal-title":"Expet Rev Clin Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib21","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in health and disease: a state-of-the-art review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.resinv.2025.04.018_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","article-title":"The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib23","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.4049\/jimmunol.158.3.1332","article-title":"Expression of IL-5 in thymocytes\/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies","volume":"158","author":"Lee","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2500\/108854199778681486","article-title":"Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome","volume":"20","author":"Tsukadaira","year":"1999","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.resinv.2025.04.018_bib25","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/rheumatology\/kes171","article-title":"Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients","volume":"51","author":"Jakiela","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/all.16395","article-title":"Bioactive mediator profile of mepolizumab-treated eosinophilic granulomatosis with polyangiitis","volume":"80","author":"Kamide","year":"2025","journal-title":"Allergy"},{"issue":"Suppl 117","key":"10.1016\/j.resinv.2025.04.018_bib27","first-page":"40","article-title":"Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma","volume":"37","author":"Pagnoux","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.653461","article-title":"Serum cytokine profiling identifies axl as a new biomarker candidate for active eosinophilic granulomatosis with polyangiitis","volume":"8","author":"Ma","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.resinv.2025.04.018_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.0000000000011142","article-title":"Association between IL-5 levels and the clinicopathologic features of eosinophilic granulomatosis with polyangiitis","volume":"96","author":"Nishi","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.resinv.2025.04.018_bib30","doi-asserted-by":"crossref","first-page":"L847","DOI":"10.1152\/ajplung.00245.2001","article-title":"IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK","volume":"282","author":"Moore","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.resinv.2025.04.018_bib31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/ken033","article-title":"Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity","volume":"47","author":"Polzer","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1073\/pnas.76.3.1443","article-title":"Neurotoxicity of human eosinophils","volume":"76","author":"Durack","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.resinv.2025.04.018_bib33","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","article-title":"Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans","volume":"121","author":"Ueki","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2025.04.018_bib34","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/art.41727","article-title":"Eosinophil ETosis-mediated release of galectin-10 in eosinophilic granulomatosis with polyangiitis","volume":"73","author":"Fukuchi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fimmu.2016.00256","article-title":"Neutrophil extracellular traps in ANCA-associated vasculitis","volume":"7","author":"S\u00f6derberg","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.801897","article-title":"Increased circulating cell-free DNA in eosinophilic granulomatosis with polyangiitis: implications for eosinophil extracellular traps and immunothrombosis","volume":"12","author":"Hashimoto","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","article-title":"Pathogenesis and therapeutic interventions for ANCA-associated vasculitis","volume":"15","author":"Nakazawa","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib38","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.3390\/jcm12185996","article-title":"Eosinophilic granulomatosis with polyangiitis: latest findings and updated treatment recommendations","volume":"12","author":"Watanabe","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121737","article-title":"Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"10","author":"Dejaco","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2025.04.018_bib40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0","article-title":"Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome","volume":"44","author":"Kiene","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib41","doi-asserted-by":"crossref","first-page":"iii84","DOI":"10.1093\/rheumatology\/kez570","article-title":"Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management","volume":"59","author":"Trivioli","year":"2020","journal-title":"Rheumatology"},{"issue":"1 Suppl 64","key":"10.1016\/j.resinv.2025.04.018_bib42","first-page":"S23","article-title":"Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome","volume":"29","author":"Jakiela","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1196\/annals.1361.053","article-title":"Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome","volume":"1051","author":"Hellmich","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.resinv.2025.04.018_bib44","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1182\/blood-2010-02-267542","article-title":"Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome","volume":"116","author":"Terrier","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.resinv.2025.04.018_bib45","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.143366","article-title":"A role for IL-33-activated ILC2s in eosinophilic vasculitis","volume":"6","author":"Kotas","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.resinv.2025.04.018_bib46","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/cea.13209","article-title":"Innate immune response reflects disease activity in eosinophilic granulomatosis with polyangiitis","volume":"48","author":"Tsurikisawa","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"7937","key":"10.1016\/j.resinv.2025.04.018_bib47","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41586-022-05395-5","article-title":"Non-redundant functions of group 2 innate lymphoid cells","volume":"611","author":"Jarick","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.resinv.2025.04.018_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102737","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis: a systematic literature review","volume":"20","author":"Akiyama","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resinv.2025.04.018_bib49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.autrev.2015.10.006","article-title":"Dividing the Janus vasculitis? Pathophysiology of eosinophilic granulomatosis with polyangitis","volume":"15","author":"Chaigne","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resinv.2025.04.018_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.627776","article-title":"Eosinophilic granulomatosis with polyangiitis: dissecting the pathophysiology","volume":"8","author":"Fagni","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib51","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1097\/RHU.0000000000001606","article-title":"Elevated serum IgG4 was found in eosinophilic granulomatosis with polyangiitis","volume":"27","author":"Wu","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4 immune response in Churg-Strauss syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib53","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ajpath.2020.03.005","article-title":"Pulmonary eosinophilic granulomatosis with polyangiitis has IgG4 plasma cells and immunoregulatory features","volume":"190","author":"Dong","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.resinv.2025.04.018_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2016.09.018","volume":"16","author":"Cottin","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resinv.2025.04.018_bib55","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib56","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/j.1398-9995.2007.01486.x","article-title":"The common allergens in the Churg-Strauss syndrome","volume":"62","author":"Bottero","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2025.04.018_bib57","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2025.04.018_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2018.07.017","article-title":"Severe\/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis","volume":"142","author":"Berti","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib59","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00016480500437435","article-title":"Ear, nose and throat manifestations of Churg-Strauss syndrome","volume":"126","author":"Bacciu","year":"2006","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.resinv.2025.04.018_bib60","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MLG.0b013e318159889d","article-title":"Nasal polyposis in Churg-Strauss syndrome","volume":"118","author":"Bacciu","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.resinv.2025.04.018_bib61","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaip.2015.12.014","article-title":"Asthma control and airway inflammation in patients with eosinophilic granulomatosis with polyangiitis","volume":"4","author":"Latorre","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.04.018_bib62","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.alit.2023.02.003","article-title":"Computed tomography findings of paranasal sinuses in patients with eosinophilic granulomatosis with polyangiitis: comparison with other eosinophilic sinus diseases and clinical relevance of their severity","volume":"72","author":"Iwata","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib64","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ki.2009.210","article-title":"Churg-Strauss syndrome","volume":"76","author":"Vaglio","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib65","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1007\/s00330-007-0700-4","article-title":"Pulmonary involvement in Churg-Strauss syndrome: an analysis of CT, clinical, and pathologic findings","volume":"17","author":"Kim","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.resinv.2025.04.018_bib66","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3988\/jcn.2017.13.1.77","article-title":"Clinical characteristics and treatment response of peripheral neuropathy in the presence of eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): experience at a single tertiary center","volume":"13","author":"Cho","year":"2017","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.resinv.2025.04.018_bib67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/RHU.0000000000000713","article-title":"Overall disability sum score for clinical assessment of neurological involvement in eosinophilic granulomatosis with polyangiitis","volume":"24","author":"Padoan","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaut.2013.03.003","article-title":"Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials","volume":"43","author":"Samson","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.resinv.2025.04.018_bib69","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000615","article-title":"Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: insights from the DCVAS study","volume":"6","author":"Bischof","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.resinv.2025.04.018_bib70","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1586\/14737175.2016.1165095","article-title":"Neurological manifestations in ANCA-associated vasculitis - assessment and treatment","volume":"16","author":"Wludarczyk","year":"2016","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.resinv.2025.04.018_bib71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/122.3.427","article-title":"Clinicopathological features of Churg-Strauss syndrome-associated neuropathy","volume":"122","author":"Hattori","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.resinv.2025.04.018_bib72","doi-asserted-by":"crossref","first-page":"e1726","DOI":"10.1212\/WNL.0000000000009309","article-title":"Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA","volume":"94","author":"Nishi","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.resinv.2025.04.018_bib73","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2012-201531","article-title":"A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients","volume":"72","author":"Moosig","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib74","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/art.41310","article-title":"Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"72","author":"Micheletti","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib75","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1007\/s10067-019-04538-w","article-title":"Clinical characteristics of Polish patients with ANCA-associated vasculitides-retrospective analysis of POLVAS registry","volume":"38","author":"W\u00f3jcik","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/mr\/road001","article-title":"Evaluation of prognostic factors for patients with eosinophilic granulomatosis with polyangiitis recruited at the pneumonological centre and mainly ANCA negativity: a retrospective analysis of a single cohort in Poland","volume":"34","author":"Fijolek","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib77","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/acr.22686","article-title":"Long-term followup of a multicenter cohort of 101 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"68","author":"Durel","year":"2016","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.resinv.2025.04.018_bib78","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3899\/jrheum.171352","article-title":"Longterm outcomes of 188 Japanese patients with eosinophilic granulomatosis with polyangiitis","volume":"45","author":"Saku","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib79","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006083","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity","volume":"96","author":"Solans-Laqu\u00e9","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2025.04.018_bib80","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sabl\u00e9-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib81","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2012.05.058","article-title":"Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome","volume":"131","author":"Healy","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00296-016-3435-1","article-title":"Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk","volume":"37","author":"Misra","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib83","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2020.12.008","article-title":"Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): prospective evaluation at a tertiary referral centre","volume":"85","author":"Zampieri","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib84","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181af35a5","article-title":"Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis","volume":"88","author":"Neumann","year":"2009","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2025.04.018_bib85","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1093\/rheumatology\/keab027","article-title":"Heart disease in eosinophilic granulomatosis with polyangiitis (EGPA) patients: a screening approach proposal","volume":"60","author":"Garcia-Vives","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib86","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2015.06.087","article-title":"Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis","volume":"199","author":"Hazebroek","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.resinv.2025.04.018_bib87","first-page":"51","article-title":"The significance of cardiac magnetic resonance imaging in detection and monitoring of the treatment efficacy of heart involvement in eosinophilic granulomatosis with polyangiitis patients","volume":"33","author":"Fijolek","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib88","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/art.27263","article-title":"Cardiac involvement in Churg-Strauss syndrome","volume":"62","author":"Dennert","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib89","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2015.04.013","article-title":"Impact of cardiac magnetic resonance imaging on eosinophilic granulomatosis with polyangiitis outcomes: a long-term retrospective study on 42 patients","volume":"14","author":"Dunogu\u00e9","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.resinv.2025.04.018_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320987051","article-title":"Cardiac manifestations of eosinophilic granulomatosis with polyangiitis from a single-center cohort in China: clinical features and associated factors","volume":"12","author":"Liu","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib91","first-page":"126","article-title":"Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series","volume":"33","author":"Monti","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2025.04.018_bib93","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/rheumatology\/keaa416","article-title":"Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases","volume":"60","author":"Durel","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib94","first-page":"S41","article-title":"ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center","volume":"32","author":"Sokolowska","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib95","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3899\/jrheum.2023-0325","article-title":"Cluster analysis to explore clinical subphenotypes of eosinophilic granulomatosis with polyangiitis","volume":"50","author":"Rubenstein","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib96","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.md.0000158825.87055.0b","volume":"84","author":"Pagnoux","year":"2005","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.resinv.2025.04.018_bib97","first-page":"20","article-title":"The basis of Churg-Strauss syndrome diagnosis in own material","volume":"80","author":"Fijo\u0142ek","year":"2012","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1016\/j.resinv.2025.04.018_bib98","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib99","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"American College of Rheumatology\/European alliance of associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib102","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","article-title":"Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome","volume":"67","author":"Khoury","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2025.04.018_bib103","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.alit.2022.08.008","article-title":"A diagnostic score for eosinophilic granulomatosis with polyangiitis among eosinophilic disorders","volume":"72","author":"Takahashi","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib104","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib105","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham vasculitis activity score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib106","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management","volume":"26","author":"Groh","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib107","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/rheumatology\/keu427","article-title":"Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis","volume":"54","author":"Grayson","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib108","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/rheumatology\/keq445","article-title":"Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study","volume":"50","author":"Zwerina","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib109","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.alit.2023.09.001","article-title":"Reduction in ANCA levels associated with mepolizumab add-on treatment in eosinophilic granulomatosis with polyangiitis: case series and literature review","volume":"73","author":"Kamide","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib110","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/all.15481","article-title":"Urine eosinophil-derived neurotoxin: a potential marker of activity in select eosinophilic disorders","volume":"78","author":"Makiya","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2025.04.018_bib111","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9343(03)00359-0","article-title":"Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists","volume":"115","author":"Keogh","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib112","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202005-1628SO","article-title":"International consensus on ANCA testing in eosinophilic granulomatosis with polyangiitis","author":"Moiseev","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib113","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/ard-2022-223764","article-title":"EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update","volume":"83","author":"Hellmich","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib114","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1093\/rheumatology\/keaa805","article-title":"Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"60","author":"Papo","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102270","article-title":"New developments in treatments for systemic vasculitis","volume":"66","author":"Goglin","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.resinv.2025.04.018_bib116","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1080\/14656566.2023.2216379","article-title":"Advances in the pharmacotherapeutic management of eosinophilic granulomatosis with polyangiitis","volume":"24","author":"Pagnoux","year":"2023","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.resinv.2025.04.018_bib117","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","article-title":"French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)","volume":"15","author":"Terrier","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib118","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/ard-2022-223237","article-title":"Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis","volume":"82","author":"Sanges","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib119","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.22679","article-title":"Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients","volume":"57","author":"Cohen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1310211","article-title":"Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases","volume":"14","author":"Del Pozo","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib121","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/art.40205","article-title":"Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg-Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial","volume":"69","author":"Pu\u00e9chal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib122","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/rheumatology\/kez139","article-title":"Non-severe eosinophilic granulomatosis with polyangiitis: long-term outcomes after remission-induction trial","volume":"58","author":"Pu\u00e9chal","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib123","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00415-014-7618-y","article-title":"Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial","volume":"262","author":"Koike","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.resinv.2025.04.018_bib124","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.intimp.2017.01.025","article-title":"Heart failure not responsive to standard immunosuppressive therapy is successfully treated with high dose intravenous immunoglobulin therapy in a patient with Eosinophilic Granulomatosis with Polyangiitis (EGPA)","volume":"45","author":"Pecoraro","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.resinv.2025.04.018_bib125","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/rheumatology\/kez311","article-title":"The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"59","author":"Shimizu","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.resinv.2025.04.018_bib126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-022-02845-3","article-title":"Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study","volume":"24","author":"Ueno","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2025.04.018_bib127","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/acr2.11571","article-title":"Clinical benefit of mepolizumab in eosinophilic granulomatosis with polyangiitis for patients with and without a vasculitic phenotype","volume":"5","author":"Terrier","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib128","first-page":"531","article-title":"Steroids-resistant EGPA-induced neuropathy with acute disease progression: how to use mepolizumab as novel targeted agent","volume":"74","author":"Hattori","year":"2022","journal-title":"Brain Nerve"},{"key":"10.1016\/j.resinv.2025.04.018_bib129","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13223-022-00653-7","article-title":"Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab","volume":"18","author":"Kai","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.alit.2020.08.005","article-title":"The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients","volume":"70","author":"Kitamura","year":"2021","journal-title":"Allergol Int"},{"key":"10.1016\/j.resinv.2025.04.018_bib131","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/mr\/roab005","article-title":"Low-dose mepolizumab is effective as an add-on therapy for treating long-lasting peripheral neuropathy in patients with eosinophilic granulomatosis with polyangiitis","volume":"32","author":"Nakamura","year":"2022","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib132","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaip.2020.09.054","article-title":"Benralizumab as a steroid-sparing treatment option in eosinophilic granulomatosis with polyangiitis","volume":"9","author":"Guntur","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.04.018_bib133","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa2311155","article-title":"Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis","volume":"390","author":"Wechsler","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib134","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.anai.2021.01.035","article-title":"Efficacy and safety of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"126","author":"Manka","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.resinv.2025.04.018_bib135","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1111\/all.16267","article-title":"Mepolizumab depletes inflammatory but preserves homeostatic eosinophils in severe asthma","volume":"79","author":"Fricker","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.resinv.2025.04.018_bib136","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4081\/mrm.2021.779","article-title":"Successful treatment with benralizumab in a patient with eosinophilic granulomatosis with polyangiitis refractory to mepolizumab","volume":"16","author":"Menzella","year":"2021","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib137","doi-asserted-by":"crossref","DOI":"10.1093\/mrcr\/rxaf008","article-title":"Successful switching treatment of mepolizumab for refractory eosinophilic granulomatosis with polyangiitis and multiple organ dysfunction under benralizumab treatment: a case report","author":"Yukishima","year":"2025","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.resinv.2025.04.018_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.754434","article-title":"Novel targets for drug use in eosinophilic granulomatosis with polyangiitis","volume":"8","author":"Uzzo","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib139","doi-asserted-by":"crossref","DOI":"10.1186\/ar4313","article-title":"Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)","volume":"15","author":"Thiel","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2025.04.018_bib140","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jaip.2017.07.027","article-title":"Rituximab as induction therapy in eosinophilic granulomatosis with polyangiitis refractory to conventional immunosuppressive treatment: a 36-month follow-up analysis","volume":"5","author":"Thiel","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.resinv.2025.04.018_bib141","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"75","author":"Mohammad","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib142","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-000905","article-title":"Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"5","author":"Teixeira","year":"2019","journal-title":"RMD Open"},{"key":"10.1016\/j.resinv.2025.04.018_bib143","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11926-020-0881-2","article-title":"Eosinophilic vasculitis","volume":"22","author":"Vega Villanueva","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.resinv.2025.04.018_bib144","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.41534","article-title":"Use of biologics to treat relapsing and\/or refractory eosinophilic granulomatosis with polyangiitis: data from a European collaborative study","volume":"73","author":"Canzian","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib145","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib146","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.3390\/ijms22094369","article-title":"Tezepelumab: a potential new biological therapy for severe refractory asthma","volume":"22","author":"Pelaia","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2025.04.018_bib147","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/ard.2007.071936","article-title":"Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League against Rheumatism systemic vasculitis task force","volume":"67","author":"Mukhtyar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib148","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11926-022-01087-1","article-title":"At the heart of eosinophilic granulomatosis with polyangiitis: into cardiac and vascular involvement","volume":"24","author":"Bond","year":"2022","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.resinv.2025.04.018_bib149","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/acr2.11263","article-title":"Clinical manifestations and long-term outcomes of eosinophilic granulomatosis with polyangiitis in north America","volume":"3","author":"Doubelt","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib150","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2025.04.018_bib151","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10067-013-2169-7","article-title":"The impact of current health-related quality of life on future health outlook in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)","volume":"32","author":"Soko\u0142owska","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.806361","article-title":"The impact of high dose glucocorticoids on bone health and fracture risk in systemic vasculitides","volume":"13","author":"Box","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.resinv.2025.04.018_bib153","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.semarthrit.2021.03.014","article-title":"The cancer risk according to three subtypes of ANCA-associated vasculitis: a propensity score-matched analysis of a nationwide study","volume":"51","author":"Choi","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resinv.2025.04.018_bib154","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3390\/jcm8111871","article-title":"Risk of cancers in antineutrophil cytoplasmic antibody-associated vasculitis: results from the Korea national health insurance claims database 2010-2018","volume":"8","author":"Ahn","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2025.04.018_bib155","first-page":"73","article-title":"Cancer development in Korean patients with ANCA-associated vasculitis: a single centre study","volume":"36","author":"Yoo","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.resinv.2025.04.018_bib156","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/1756-185X.13056","article-title":"Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis","volume":"20","author":"Kim","year":"2017","journal-title":"Int J Rheum Dis"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534525000607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:50:40Z","timestamp":1749599440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534525000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":155,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2212534525000607"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.018","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophilic granulomatosis with polyangiitis: current status and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2025.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}